Klotho Neurosciences Inc/$GRML
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Klotho Neurosciences Inc
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
Ticker
$GRML
Sector
Primary listing
Employees
5
Headquarters
Website
GRML Metrics
BasicAdvanced
$39m
-
-$0.34
2.62
-
Price and volume
Market cap
$39m
Beta
2.62
52-week high
$1.67
52-week low
$0.21
Average daily volume
3.5m
Financial strength
Current ratio
19.742
Quick ratio
18.064
Interest coverage (TTM)
-8.56%
Profitability
Management effectiveness
Return on assets (TTM)
-30.04%
Return on equity (TTM)
-85.56%
Valuation
Price to book
0.75
Price to tangible book (TTM)
13.84
Price to free cash flow (TTM)
-2.147
Free cash flow yield (TTM)
-46.57%
Free cash flow per share (TTM)
-0.149
Growth
Earnings per share change (TTM)
0.84%
3-year earnings per share growth (CAGR)
721.15%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs